Physician profile
Lusia Filetti
NPI 1841498532
$1,410.87
in general payments reported to CMS, 2019-2025
15 companies · $595 in 2025
The $595 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22.89 · 2020: $35.79 · 2021: $134 · 2022: $15.16 · 2023: $165 · 2024: $443 · 2025: $595.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,202.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $336.78 | 2024-2025 | Zurzuvae |
| Shield Therapeutics INC | $336.15 | 2023-2025 | Accrufer |
| Pfizer INC. | $182.11 | 2019-2024 | |
| Exeltis, USA INC. | $159.73 | 2023-2025 | Slynd, Tyblume, Nuvessa |
| Axsome Therapeutics, INC. | $64.30 | 2025 | Auvelity |
| Merck Sharp & Dohme LLC | $50.14 | 2021-2022 | |
| Novo Nordisk INC | $48.47 | 2024-2025 | Wegovy |
| Sumitomo Pharma America, INC. | $45.78 | 2025 | Myfembree |
| Pacira Pharmaceuticals Incorporated | $43.44 | 2023-2024 | Exparel |
| Hologic Sales and Service, LLC | $43.29 | 2021-2025 | Myosure Tissue Removal Device |
| Astellas Pharma US INC | $32.07 | 2024 | Veozah |
| Optumhealth Care Solutions, LLC | $25.42 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Ethicon US, LLC | $18.72 | 2021 | |
| Lilly USA, LLC | $13.40 | 2024 | Jardiance, Zepbound |
| Mylan Pharmaceuticals INC. | $11.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lusia Filetti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.